Pregna Plus without iron is a dietary supplement containing a carefully selected set of nutrients in amounts adapted to the needs of pregnant women.
Pregna brand preparations are manufactured in pharmaceutical plants with GMP certificate. They are verified in terms of the content of active substances, allergens, microbiological purity and the origin of raw materials to ensure they are of the highest possible quality.
The ingredients whose positive effect has been clearly proven include folic acid, polyunsaturated fatty acids, iodine and vitamin D¹. The product contains the active form of folic acid, calcium L-methylfolate, which is a biologically available form of folate, making it easier and faster to absorb.
Pregna Plus without iron was developed according to Evidence Based Medicine standards. Contains ingredients recommended by the Polish Society of Gynecologists and Obstetricians: folic acid, iodine, vitamin D and DHA from the omega-3 family
The ingredients of the Pregna Plus dietary supplement without iron perform many important functions in the body, which physiologically influence the proper course of pregnancy. Supplemental intake of folic acid increases maternal folate levels. Low maternal folate levels are a risk factor for the development of neural tube defects in the developing fetus². There are many risk factors for developing neural tube defects and changing one of them may or may not have a beneficial effect. The source of DHA in the product is highly purified oil from fatty marine fish obtained using the PureMax technology.
In accordance with the position of the Polish Group of Experts on supplementation of DHA and other omega-3 fatty acids in the pregnant and breastfeeding population, DHA supplementation is recommended to ensure proper resources of this ingredient in the mother's body and ensure its proper distribution to the fetus. Until birth, the baby absorbs the necessary amounts of DHA from the mother's body, and after delivery, the newborn baby receives it with her food.

1. Recommendations of the Polish Society of Gynecologists and Obstetricians regarding supplementation in pregnant women, 2020.
2. European Commission Regulation (EU) No. 1135/2014 of 24/10/2014 conditions of use of the health claim for folic acid - The product is intended for women of reproductive age, and the beneficial effect occurs with a daily supplementary intake of 400 μg of folic acid by at least one month before conception and a maximum of three months after conception.
3. Position of the Expert Group on supplementation of DHA and other omega-3 fatty acids in the population of pregnant women, breastfeeding women and infants and children up to 3 years of age. Standardy Medyczne/Pediatria 2010, pp. 729-736